Results 331 to 340 of about 343,907 (366)
Some of the next articles are maybe not open access.
EDTNA-ERCA Journal, 2006
The reality is that the majority of the CKD population have one or more co-morbid conditions with a known higher prevalence in ethnic minorities and lower socio-economic groups; combine this with the increase in childhood obesity and prevalence of diabetes and it is clear why we have an epidemic of CKD.
openaire +2 more sources
The reality is that the majority of the CKD population have one or more co-morbid conditions with a known higher prevalence in ethnic minorities and lower socio-economic groups; combine this with the increase in childhood obesity and prevalence of diabetes and it is clear why we have an epidemic of CKD.
openaire +2 more sources
Mitochondrial Dysfunction and the AKI to CKD Transition.
AJP - Renal Physiology, 2020Acute kidney injury (AKI) has been widely recognized as an important risk factor for the occurrence and development of chronic kidney disease (CKD). Even milder AKI has adverse consequences and could progress to renal fibrosis, which is the ultimate ...
Mingzhu Jiang +6 more
semanticscholar +1 more source
Advances in Chronic Kidney Disease, 2011
The diagnosis of hereditary monogenic kidney diseases is frequently delayed, in part because of physicians' unfamiliarity with the relatively rare conditions or because of the late onset of symptoms in some patients. Molecular biology methods have clarified the underlying mutations in several types of CKD, and in the process have revealed previously ...
openaire +2 more sources
The diagnosis of hereditary monogenic kidney diseases is frequently delayed, in part because of physicians' unfamiliarity with the relatively rare conditions or because of the late onset of symptoms in some patients. Molecular biology methods have clarified the underlying mutations in several types of CKD, and in the process have revealed previously ...
openaire +2 more sources
BMJ, 2010
The concept of chronic kidney disease (CKD) is bad medicine only because we have made it so.1 The concepts of reduced renal excretory function and CKD have been conflated so people who do not have CKD—such as patients who have had a nephrectomy for reasons not related to the function of …
openaire +2 more sources
The concept of chronic kidney disease (CKD) is bad medicine only because we have made it so.1 The concepts of reduced renal excretory function and CKD have been conflated so people who do not have CKD—such as patients who have had a nephrectomy for reasons not related to the function of …
openaire +2 more sources
Ergocalciferol and Cholecalciferol in CKD
American Journal of Kidney Diseases, 2012The development of chronic kidney disease (CKD) is accompanied by a progressive decrease in the ability to produce 1,25-dihydroxyvitamin D. Pharmacological replacement with active vitamin D therefore has been a cornerstone of secondary hyperparathyroidism therapy in the end-stage renal disease population treated by long-term dialysis.
Sagar U, Nigwekar +2 more
openaire +2 more sources
Is Arsenic a Contributor to CKD?
American Journal of Kidney Diseases, 2013rsenic has a fascinating and checkered history. Ithas been a popular poison for at least 2,000years because it is colorless and tasteless, yet it alsocommonly was used therapeutically in the 19th andearly 20th century in Fowler’s solution (1% potas-sium arsenite), Donovan’s solution (arsenic iodide),and deValagin’s solution (arsenic trichloride) to ...
Kathy, James, Jaymie R, Meliker
openaire +2 more sources
Targeting innate immunity-driven inflammation in CKD and cardiovascular disease
Nature Reviews Nephrology, 2022T. Speer +4 more
semanticscholar +1 more source
American Journal of Kidney Diseases
Chronic systemic inflammation, triggered by innate immune system activation, is a key driver of both chronic kidney disease and associated atherosclerosis and cardiovascular disease. Directly targeting inflammatory pathways has emerged over the past 15 years as a novel approach under active investigation to reduce atherosclerotic cardiovascular disease
Kristen L. Nowak, Michel Chonchol
openaire +2 more sources
Chronic systemic inflammation, triggered by innate immune system activation, is a key driver of both chronic kidney disease and associated atherosclerosis and cardiovascular disease. Directly targeting inflammatory pathways has emerged over the past 15 years as a novel approach under active investigation to reduce atherosclerotic cardiovascular disease
Kristen L. Nowak, Michel Chonchol
openaire +2 more sources
Current Opinion in Nephrology and Hypertension, 2012
Fractures are a common problem in chronic kidney disease (CKD). The 2009 KDIGO (Kidney Disease: Improving Global Outcomes) review of the bone and mineral disorders highlighted areas of uncertainty and stressed the importance of further research. This review includes studies published since that report with a focus on the bone.Bone biopsies have shown a
openaire +2 more sources
Fractures are a common problem in chronic kidney disease (CKD). The 2009 KDIGO (Kidney Disease: Improving Global Outcomes) review of the bone and mineral disorders highlighted areas of uncertainty and stressed the importance of further research. This review includes studies published since that report with a focus on the bone.Bone biopsies have shown a
openaire +2 more sources